Lv11
30 积分 2024-06-14 加入
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States
3小时前
已完结
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – EDF in cooperation with EADV and IPC
2个月前
已完结
Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosis
4个月前
已完结
New onset atopic dermatitis and psoriasis in the same patients under biologic treatments: The role of systemic treatments as a possible trigger
4个月前
已完结
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature
4个月前
已完结
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI
4个月前
已完结
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
4个月前
已完结
Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies
4个月前
已完结
Injection site reactions with the use of biological agents
6个月前
已完结
Treatment of psoriasis with biological agents: a Chinese expert consensus statement （2019）
6个月前
已完结
皖公网安备34019202002308
